Atlas Trials

Rucaparib MAintenance After Bevacizumab Maintenance Following Carboplatin Based First Line Chemotherapy in Ovarian Cancer Patients

Clinical trial NCT04227522 · COMPLETED

Trial details

NCT number
NCT04227522
Sponsor
North Eastern German Society of Gynaecological Oncology
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian CancerFallopian Tube CancerPrimary Peritoneal CancerClear Cell Carcinoma
Start date
2020-06-08
Primary completion
2023-12-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.